PUBLISHER: 360iResearch | PRODUCT CODE: 1586131
PUBLISHER: 360iResearch | PRODUCT CODE: 1586131
Cardiovascular Implants Market by Type (Cardiac Resynchronization Therapy Device, Coronary Stents, Heart Valves), End-User (Cardiac Care Centers, Hospitals, Specialty Clinics) - Global Forecast 2025-2030
The Cardiovascular Implants Market was valued at USD 33.26 billion in 2023, expected to reach USD 35.30 billion in 2024, and is projected to grow at a CAGR of 6.21%, to USD 50.72 billion by 2030.
The cardiovascular implants market encompasses medical devices used to repair or replace damaged heart tissues and vessels, broadly including stents, pacemakers, defibrillators, heart valves, and ventricular assist devices. Their necessity is driven by rising incidences of cardiovascular diseases (CVDs), often attributed to aging populations, sedentary lifestyles, and increasing prevalence of obesity. Applications range from treating arrhythmias with pacemakers, unclogging blocked arteries with stents, to supporting heart function via assist devices, primarily used in hospitals, ambulatory surgical centers, and cardiac care centers. Key growth influencers include technological advancements fostering minimally invasive procedures, a surge in healthcare expenditure, and robust demand bolstered by escalating patient awareness and improving healthcare infrastructure in emerging markets. Notably, opportunities abound in the innovation of biocompatible materials, AI-driven diagnostics, and improvements in robotic-assisted surgeries to enhance precision and reduce recovery times. However, limitations such as high procedure costs, stringent regulatory landscapes, and potential device malfunctions pose significant challenges. Issues like limited reimbursement in developing regions and lengthy approval processes further complicate the scenario. Despite these barriers, businesses can concentrate on research and development in biodegradable stents and next-generation defibrillators to fortify market position. The growing telemedicine trend also suggests potential for remote monitoring solutions integrated with cardiovascular implants, opening avenues for continuous patient care and data collection. Market nature remains competitive with players focusing on strategic collaborations, mergers to capitalize on technological prowess, and expand geographic reach. Companies should stay attuned to evolving patient needs, regulatory frameworks, and competitive actions in order to harness full market potential. Innovation should lean towards enhancing device longevity and reducing invasive nature, thereby improving patient outcomes and cost-efficacy.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 33.26 billion |
| Estimated Year [2024] | USD 35.30 billion |
| Forecast Year [2030] | USD 50.72 billion |
| CAGR (%) | 6.21% |
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiovascular Implants Market
The Cardiovascular Implants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Increasing health consciousness and growing occurrences of cardiovascular disorders
- Favorable reimbursement policies by government agencies
- Improved efficacy and safety of cardiovascular implants
- Market Restraints
- Strict approval process and high cost of devices
- Market Opportunities
- 3D printing of implants and development of medical Biopolymers and biomaterials
- Development of smart cardiovascular implants
- Market Challenges
- Complicated implant design, biofunctionalization, and process development
Porter's Five Forces: A Strategic Tool for Navigating the Cardiovascular Implants Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiovascular Implants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Cardiovascular Implants Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiovascular Implants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Cardiovascular Implants Market
A detailed market share analysis in the Cardiovascular Implants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiovascular Implants Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiovascular Implants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiovascular Implants Market
A strategic analysis of the Cardiovascular Implants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Cardiovascular Implants Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Artivion, Inc., B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cardiac Implants, LLC, Edwards Lifesciences Corporation, Johnson & Johnson Services, Inc., LivaNova PLC, Medtronic PLC, Neovasc Inc., Sorin Corporation, and Terumo Corporation.
Market Segmentation & Coverage
This research report categorizes the Cardiovascular Implants Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Type, market is studied across Cardiac Resynchronization Therapy Device, Coronary Stents, Heart Valves, Implantable Cardioverter Defibrillator, Implanted Cardiac Pacemakers, and Peripheral Stents.
- Based on End-User, market is studied across Cardiac Care Centers, Hospitals, and Specialty Clinics.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing health consciousness and growing occurrences of cardiovascular disorders
- 5.1.1.2. Favorable reimbursement policies by government agencies
- 5.1.1.3. Improved efficacy and safety of cardiovascular implants
- 5.1.2. Restraints
- 5.1.2.1. Strict approval process and high cost of devices
- 5.1.3. Opportunities
- 5.1.3.1. 3D printing of implants and development of medical Biopolymers and biomaterials
- 5.1.3.2. Development of smart cardiovascular implants
- 5.1.4. Challenges
- 5.1.4.1. Complicated implant design, biofunctionalization, and process development
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Cardiovascular Implants Market, by Type
- 6.1. Introduction
- 6.2. Cardiac Resynchronization Therapy Device
- 6.3. Coronary Stents
- 6.4. Heart Valves
- 6.5. Implantable Cardioverter Defibrillator
- 6.6. Implanted Cardiac Pacemakers
- 6.7. Peripheral Stents
7. Cardiovascular Implants Market, by End-User
- 7.1. Introduction
- 7.2. Cardiac Care Centers
- 7.3. Hospitals
- 7.4. Specialty Clinics
8. Americas Cardiovascular Implants Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
9. Asia-Pacific Cardiovascular Implants Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
10. Europe, Middle East & Africa Cardiovascular Implants Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
11. Competitive Landscape
- 11.1. Market Share Analysis, 2023
- 11.2. FPNV Positioning Matrix, 2023
- 11.3. Competitive Scenario Analysis
- 11.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Abbott Laboratories
- 2. Artivion, Inc.
- 3. B. Braun Melsungen AG
- 4. BIOTRONIK SE & Co. KG
- 5. Boston Scientific Corporation
- 6. Cardiac Implants, LLC
- 7. Edwards Lifesciences Corporation
- 8. Johnson & Johnson Services, Inc.
- 9. LivaNova PLC
- 10. Medtronic PLC
- 11. Neovasc Inc.
- 12. Sorin Corporation
- 13. Terumo Corporation
LIST OF FIGURES
- FIGURE 1. CARDIOVASCULAR IMPLANTS MARKET RESEARCH PROCESS
- FIGURE 2. CARDIOVASCULAR IMPLANTS MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 11. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 13. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 15. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. CARDIOVASCULAR IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 19. CARDIOVASCULAR IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. CARDIOVASCULAR IMPLANTS MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. CARDIOVASCULAR IMPLANTS MARKET DYNAMICS
- TABLE 7. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY DEVICE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CORONARY STENTS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTED CARDIAC PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL STENTS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CARDIAC CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 19. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 20. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 21. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 22. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 23. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 24. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 25. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 26. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 27. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 28. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 29. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 30. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 31. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 32. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 33. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 34. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 35. AUSTRALIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 36. AUSTRALIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 37. CHINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 38. CHINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 39. INDIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 40. INDIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 41. INDONESIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 42. INDONESIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 43. JAPAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 44. JAPAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 45. MALAYSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 46. MALAYSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 47. PHILIPPINES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 48. PHILIPPINES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 49. SINGAPORE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 50. SINGAPORE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 51. SOUTH KOREA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 52. SOUTH KOREA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 53. TAIWAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 54. TAIWAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 55. THAILAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 56. THAILAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 57. VIETNAM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 58. VIETNAM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 59. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 60. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 61. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 62. DENMARK CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 63. DENMARK CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 64. EGYPT CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 65. EGYPT CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 66. FINLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 67. FINLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 68. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 69. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 70. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 71. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 72. ISRAEL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 73. ISRAEL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 74. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 75. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 76. NETHERLANDS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 77. NETHERLANDS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 78. NIGERIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 79. NIGERIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 80. NORWAY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 81. NORWAY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 82. POLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 83. POLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 84. QATAR CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 85. QATAR CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 86. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 87. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 88. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 89. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 90. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 91. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 92. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 93. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 94. SWEDEN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 95. SWEDEN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 96. SWITZERLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 97. SWITZERLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 98. TURKEY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 99. TURKEY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 100. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 101. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 102. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 103. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 104. CARDIOVASCULAR IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 105. CARDIOVASCULAR IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023
